Rheumatology NewsHydroxychloroquine, abatacept linked with reduced type 2 diabetesJune 10, 2016Rheumatoid Arthritis
Rheumatology NewsMethotrexate in RA: Too low, too short, too few subcutaneous doses?June 7, 2016Rheumatoid Arthritis
Rheumatology NewsDoctors ask Congress to stop Part B drug payment testMay 17, 2016SpondyloarthropathiesAnkylosing spondylitisPsoriatic ArthritisRheumatoid ArthritisBusiness of Medicine
Rheumatology NewsPIANO study provides insight on safety of biologics in pregnancyMay 11, 2016Rheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitisPsoriatic Arthritis
Rheumatology NewsRemicade to infliximab biosimilar switches fare well in real-life practiceMay 3, 2016SpondyloarthropathiesRheumatoid ArthritisAnkylosing spondylitisPsoriatic Arthritis
Rheumatology NewsAfter Inflectra’s approval, challenges remain for biosimilarsApril 26, 2016Rheumatoid ArthritisAnkylosing spondylitisPsoriatic ArthritisLupus & Connective Tissue DiseasesPediatricsSpondyloarthropathies
Rheumatology NewsImaging can predict who’ll progress from nonspecific symptoms to arthritisApril 26, 2016Rheumatoid Arthritis
Rheumatology NewsRosacea linked to several autoimmune diseases in womenApril 13, 2016Rheumatoid Arthritis
Rheumatology NewsStudy details synovial features in RA remission and shift back to active diseaseApril 8, 2016Rheumatoid Arthritis
Rheumatology NewsInflectra becomes first FDA-approved biosimilar for inflammatory diseasesApril 5, 2016Rheumatoid ArthritisAnkylosing spondylitisPsoriatic ArthritisSpondyloarthropathies
Rheumatology NewsEarly RA remission more unstable in the presence of foot synovitisMarch 30, 2016Rheumatoid Arthritis
